Infectious side effects of cancer treatment in children. Clinical and genetic aspects
PhD ceremony: Ms. E.M. te Poele, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Infectious side effects of cancer treatment in children. Clinical and genetic aspects
Promotor(s): prof. E.S.J.M de Bont, prof. W.A. Kamps
Faculty: Medical Sciences
Chemotherapy has significantly improved the survival of children with cancer. One of the side effects of chemotherapy is the inhibited production of white blood cells. This effect predisposes for infections and infectious complications. Therefore, fever during neutropenia (lack of a specific type of white blood cells) is treated with intravenous antibiotics. The first part of this thesis deals with clinical issues. We examined the possibilities for a better risk assessment of fever during neutropenia to prevent overtreatment of patients with a low risk for bacterial infections. This cost-efficient approach may contribute to a better quality of life.
Subsequently, we studied the number of infectious deaths during the ALL-9 protocol (treatment for acute lymphoblastic leukemia (ALL) in children). We found an increase in the number of infectious deaths compared to previous protocols. This is most probably caused by repeated, prolonged treatment with the drug Dexamethasone in ALL-9. Furthermore, the use of Pegfilgrastim was evaluated. This medicine may be administered to reduce chemotherapy induced neutropenia. Pegfilgrastim is only registered for use in adults, but also seems to be safe for children. Lastly, we studied the mortality of non-elective ICU admissions in children with cancer. One of the conclusions of this study is that the survival of these children increased significantly. The second part of this thesis concerns several studies of genetic variants and the risk of developing ALL and (fever during) neutropenia. It was concluded that particular genetic variants that are associated with atopy have an inverse association with ALL.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...
-
04 July 2025
University of Groningen awards various prizes during Ceremony of Merits
The UG awarded different prizes to excellent researchers and students during the Ceremony of Merits on 4 July 2025.
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.